Despite the dedicated efforts of healthcare providers, the prevalence of obesity in the U.S. increased from 30.5% in 2000 to 41.9% in 2020. Obesity-related conditions (including heart disease, certain cancers, and type 2 diabetes) remain the leading causes of preventable death and place a significant financial burden on the U.S. healthcare system, costing over $173 billion annually.

The introduction of GLP-1 medications, like Ozempic and Wegovy, offers hope for long-term population health improvements. However, the surging demand for these medications is creating a significant strain on employers, with skyrocketing costs becoming an immediate challenge.

At Amino Health, we provide Intelligent Routing for GLP-1s to help employers manage these rising costs while empowering members with effective care solutions.

How It Works:

• Smart Search Redirection: Members searching for terms like "GLP-1," "Ozempic," or "Wegovy" on Amino are seamlessly guided to tailored resources, customizable to your programs.
• Integrated Care Programs: We connect members to your existing metabolic health or pharmacy benefit initiatives, ensuring resources are utilized efficiently.
• Education and Support: Members gain access to patient-friendly modules with key information about GLP-1s. For those needing additional guidance, our care team offers personalized support to find the best care options.

Why This Matters:

• Cost Control: Minimize surprise expenses while delivering high-value care.
• Member Satisfaction: Provide clear, actionable options for members actively seeking solutions.
• Seamless Integration: This live feature can be activated during implementation or added to existing setups for current clients.

Let’s Build Smarter Care Together
Amino Health is your partner in navigating the complexities of GLP-1 management. With tailored search and support, we ensure members have easy access to affordable, high-quality care.